Our present study using a mouse experimental system provides the scientific foundation for the development of a pancreas–gut barrier axis-based GP2-mediated defense system for the control of the penetration of commensal and/or pathogenic bacteria through the intestinal epithelium during intestinal inflammation, which will useful for developing potential preventive or therapeutic therapies for human intestinal inflammation. Here, GP2 is linked to inflammation.